Patients
Dupuytren Disease is a global problem. At least 10 million Americans and many more worldwide have one or more fingers bent from Dupuytren contracture. Many more have early-stage Dupuytren disease which has not yet progressed enough to bend the fingers. One-quarter of senior white men have some evidence of Dupuytren disease in their hands.
Dupuytren Disease is a family problem. Family history studies strongly suggest that Dupuytren disease is genetic. The strongest risk factor for developing Dupuytren disease is having a parent or sibling with the condition. Severe disease is more likely if both parents are affected. The genetic link may lead to better treatment options, but so far, a culprit gene has not been identified.
Dupuytren disease is a personal problem. The severity of Dupuytren disease varies considerably from person to person. Because of this, the only way to tell how well a treatment works is to study the stories of many people. This is why our research goal is to enroll 10,000 people with Dupuytren disease and 1000 more people without Dupuytren disease. Data on this scale is needed to solve the mystery of Dupuytren biology and make progress to a cure. This research is about you: make this research possible by enrolling in the International Dupuytren Data Bank.
Learn More
Latest News
Recent Dupuytren Publications
- Mortality in patients with Dupuytren's disease in the first 5 years after diagnosis: a population-based survival analysis
- The impact of rising NHS waiting list times on elective surgery for Dupuytren's disease
- Comparing Complications and Patient Satisfaction Following Injectable Collagenase Versus Limited Fasciectomy for Dupuytren's Disease: A Systematic Review and Meta-Analysis
- Pain-Relieving Effects of Shockwave Therapy for Ledderhose Disease: An Ultrasound-Based Study of an Unusual Bilateral Case
- Surgery, Needle Fasciotomy, or Collagenase Injection for Dupuytren Contracture : A Randomized Controlled Trial